Observatory of Patients With Metastatic ProstAte Adenocarcinoma That is Resistant to Castration and Multi-LinE Strategies
Condition(s):Metastatic Prostate AdenocarcinomaLast Updated:November 6, 2019Recruiting
Hide Studies Not Open or Pending
Condition(s):Metastatic Prostate AdenocarcinomaLast Updated:November 6, 2019Recruiting
Condition(s):Adenocarcinoma of the ProstateLast Updated:January 31, 2023Active, not recruiting
Condition(s):Adenocarcinoma of the ProstateLast Updated:October 18, 2022Completed
Condition(s):Prostate AdenocarcinomaLast Updated:March 15, 2022Unknown status
Condition(s):Prostate AdenocarcinomaLast Updated:February 21, 2024Terminated
Condition(s):Ischemic Heart Disease; Prostate AdenocarcinomaLast Updated:March 23, 2018Unknown status
Condition(s):Prostate AdenocarcinomaLast Updated:February 21, 2024Withdrawn
Condition(s):Adenocarcinoma of the Prostate; Recurrent Prostate Cancer; Stage IV Prostate CancerLast Updated:January 24, 2013Terminated
Condition(s):Prostate AdenocarcinomaLast Updated:March 29, 2017Completed
Condition(s):Prostate AdenocarcinomaLast Updated:February 27, 2014Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.